Anti-SARS-CoV-2 Spike S1 Antibody, Mouse IgG1 (AS59)

Anti-SARS-CoV-2 Spike S1 Antibody, Mouse IgG1 (AS59) (S1N-S59A1), originally from mouse immunized with recombinant SARS-CoV-2 Spike S1 protein, is produced from hybridoma.

It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Hybridoma

Mouse

Spike S1

Unconjugated

Mouse IgG1 | Mouse Kappa

-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution._x000D_For long term storage, the product should be stored at lyophilized state at -20°C or lower._x000D_Please avoid repeated freeze-thaw cycles.

95%

Immobilized SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H1) at 2 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Spike S1 Antibody, Mouse IgG1 (AS59) (Cat. No. S1N-S59A1) with a linear range of 0.08-3 ng/mL (QC tested).

Powder

PBS, pH7.4

Trehalose

Room Temperature

-20°C